Biologically Active Peptides
Bioactive peptide
Bioactive peptides have a protective effect against oxidative damage acting as free radical scavengers and metal ion chelators against enzymatic and non‐enzymatic peroxidation of lipids and essential fatty acids. Another field of action of bioactive peptides is related to their antimicrobial and immunomodulatory effect. In addition, the effects of numerous of these peptides have been investigated by Peptide Pharma Nova team on a variety of cancer cell lines and disease models.
Showing 433–468 of 1047 results
Nombre
Catalogue
Target
Category
Subcategory
-
Peptide name
Catalogue
PPH08-0424Target
Regulatory role in multiple cancer types.Category
-
Peptide name
Catalogue
PPH08-0425Target
Endogenous neuropeptide and potent vasoconstrictor. Displays selectivity for the putative ETC endothelin receptor.Category
-
Peptide name
Catalogue
PPH08-0426Target
Endogenous neuropeptide and potent vasoconstrictor. Displays selectivity for the putative ETC endothelin receptor.Category
-
Peptide name
Catalogue
PPH08-0434Target
Antiretroviral medications known as fusion inhibitors.Category
-
Peptide name
Catalogue
PPH08-0438Target
Enterotoxigenic E.coli are able to produce several toxic peptides which may cause acute diarrhea in humans and domestic animals.Category
-
Peptide name
Catalogue
PPH08-0435Target
E. coli Enterotoxin. Gastrointestinal ResearchCategory
-
Peptide name
Catalogue
PPH08-0433Target
Originally derived from a protein obtained from the venom of Southeastern Pygmy Rattlesnake, this cyclic heptapeptide is an anti-platelet which binds to glycoprotein IIb-IIIa.Category
-
Peptide name
Catalogue
PPH08-0436Target
The binding of estrogen to ER induces a conformational change and triggers a cascade of events, including dissociation from heat shock proteins, receptor dimerization, phosphorylation and the association of the hormone activated receptor with specific regCategory
-
Catalogue
PPH08-0437Target
EBAG9 promotes progression of bladder cancer. In rheumatoid arthritis, the deficiency of EBAG9 induces CTL infiltration through failure to evade immune attack, therefore leading to apoptosis of the synovial lining cells. EBAG9 is involved in controlling eCategory
-
Peptide name
Catalogue
PPH08-0420Target
GLP-1 Receptor Antagonist.Category
-
Peptide name
Catalogue
PPH08-0432Target
GLP-1 (Glucagon-Like Peptide-1) Receptor Agonist.Category
-
Peptide name
Catalogue
PPH08-0449Target
FGF-19, has been shown to cause resistance to diet-induced obesity and desensitization and to improve glucose and lipid profiles in diabetic rodents. Since these effects, at least in part, are mediated through the observed changes in metabolic rates.Category
-
Peptide name
Catalogue
PPH08-0441Target
Cell adhesion and migration processes including embryogenesis, wound healing, blood coagulation, host defense, and metastasis.Category
-
Peptide name
Catalogue
PPH08-0442Target
Cell adhesion and migration processes including embryogenesis, wound healing, blood coagulation, host defense, and metastasis.Category
-
Peptide name
Catalogue
PPH08-0443Target
Cell adhesion and migration processes including embryogenesis, wound healing, blood coagulation, host defense, and metastasis.Category
-
Peptide name
Catalogue
PPH08-0444Target
Cell adhesion and migration processes including embryogenesis, wound healing, blood coagulation, host defense, and metastasis.Category
-
Peptide name
Catalogue
PPH08-0448Target
Adhesion Molecules & Extracellular Matrix Proteins. Regenerative MedicineCategory
-
Peptide name
Catalogue
PPH08-0453Target
Novel Neuropeptide Shown to Have Neuroprotective Effects by Increasing Phosphorylation of AktCategory
-
Peptide name
Catalogue
PPH08-0454Target
Due to its toxicity, by its ability to form oximes with carbonyl-containing biomolecules, it is produced by legumes as protection from herbivores. L-Canaline possesses anti-tumor activity against human acute leukemia T-cells, and as a result is of intereCategory
-
Peptide name
Catalogue
PPH08-0450Target
Lipopeptide building block, For researchers investigating TLR2 receptor targeting vaccine programs and for use as a lipopeptide building block.Category
-
Peptide name
Catalogue
PPH08-0445Target
Molluscan Cardioexcitatory NeuropeptideCategory
-
Peptide name
Catalogue
PPH08-0446Target
Molluscan Cardioexcitatory NeuropeptideCategory
-
Peptide name
Catalogue
PPH08-0451Target
FXYD domain-containing ion transport regulator 5 (FXYD5) is a cancer-associated cell membrane glycoprotein which is a part of the FXYD family. FXYD5 is engaged in down-regulation of E-cadherin, which takes part in tumor development and metastasis and resuCategory
-
Peptide name
Catalogue
PPH08-0484Target
Ddimer, When 99mTc-labeled, this cyclic RGD dimer is a useful tool for tumor imaging. This novel galacto RGD dimer has enhanced hydrophilic properties that improve biodistribution and tumor-imaging in comparison to 3P-RGD2 tracer.Category
-
Peptide name
Catalogue
PPH08-0486Target
Glycosylated RGD for RadiolabellingCategory
-
Peptide name
Catalogue
PPH08-0456Target
Displays several important physiological activities.Category
-
Peptide name
Catalogue
PPH08-0457Target
Displays several important physiological activities.Category
-
Peptide name
Catalogue
PPH08-0481Target
Inhibitor for Collagenases and MMPsCategory
-
Peptide name
Catalogue
PPH08-0499Target
High levels of Gamma-Synuclein have been found in advanced breast carcinomas suggesting a correlation between overexpression of SNCG and breast tumor development. Synuclein-Gamma is found mostly in the peripheral nervous system (in primary sensory neuronsCategory
-
Catalogue
PPH08-0490Target
High levels of Gamma-Synuclein have been found in advanced breast carcinomas suggesting a correlation between overexpression of SNCG and breast tumor development. Synuclein-Gamma is found mostly in the peripheral nervous system (in primary sensory neuronsCategory
-
Peptide name
Catalogue
PPH08-0458Target
A Potential Growth Factor in Some Cancer Tumors, Including Prostate CancerCategory
-
Peptide name
Catalogue
PPH08-0459Target
A Potential Growth Factor in Some Cancer Tumors, Including Prostate CancerCategory
-
Peptide name
Catalogue
PPH08-0487Target
GDNF promotes the survival and differentiation of dopaminergic neurons in culture, and is able to prevent apoptosis of motor neurons induced by axotomy. The encoded protein is processed to a mature secreted form that exists as a homodimer. The mature formCategory
-
Peptide name
Catalogue
PPH08-0461Target
Negative inotropic effects in papillary muscle and displays cardioprotective activity. Inhibits cell proliferation in breast and prostate cancer cell lines. Promotes adipogenesis in vivo.Category
-
Peptide name
Catalogue
PPH08-0462Target
Negative inotropic effects in papillary muscle and displays cardioprotective activity. Inhibits cell proliferation in breast and prostate cancer cell lines. Promotes adipogenesis in vivo.Category
-
Peptide name
Catalogue
PPH08-0463Target
measure & quantify Ghrelin levels in Metabolism & Endocrine research.Category